메뉴 건너뛰기




Volumn 55, Issue 4, 2010, Pages 877-879

Rifaximin and crohn's disease: A new solution to an old problem?

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CIPROFLOXACIN; CORTICOSTEROID; IMMUNOMODULATING AGENT; METRONIDAZOLE; PLACEBO; PROBIOTIC AGENT; RIFAXIMIN; ANTIINFECTIVE AGENT; GASTROINTESTINAL AGENT; RIFAMYCIN;

EID: 77950352413     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-010-1140-6     Document Type: Editorial
Times cited : (8)

References (17)
  • 1
    • 77950344360 scopus 로고    scopus 로고
    • Adjunctive antibiotic therapy with rifaximin may help reduce Crohn's disease activity
    • doi: 10.1007/s10620-009-1111-y
    • Shafran I, Burgunder P. Adjunctive antibiotic therapy with rifaximin may help reduce Crohn's disease activity. Dig Dis Sci. 2010. doi: 10.1007/s10620-009-1111-y
    • (2010) Dig Dis Sci.
    • Shafran, I.1    Burgunder, P.2
  • 2
    • 2442699228 scopus 로고    scopus 로고
    • Specificities of inflammatory bowel disease in childhood
    • DOI 10.1016/j.bpg.2004.01.002, PII S1521691804000101
    • AM Griffiths 2004 Specificities of inflammatory bowel disease in childhood Best Pract Res Clin Gastroenterol 18 509 523 10.1016/j.bpg.2004.01.002 15157824 (Pubitemid 38667463)
    • (2004) Best Practice and Research: Clinical Gastroenterology , vol.18 , Issue.3 , pp. 509-523
    • Griffiths, A.M.1
  • 3
    • 0000153298 scopus 로고    scopus 로고
    • Enteric microflora in IBD: Pathogens or commensals?
    • 10.1002/ibd.3780030309
    • RB Sartor 1997 Enteric microflora in IBD: pathogens or commensals? Inflamm Bowel Dis 3 230 235 10.1002/ibd.3780030309
    • (1997) Inflamm Bowel Dis , vol.3 , pp. 230-235
    • Sartor, R.B.1
  • 4
    • 0031781603 scopus 로고    scopus 로고
    • Inflammatory bowel disease: Etiology and pathogenesis
    • DOI 10.1016/S0016-5085(98)70381-6
    • C Fiocchi 1998 Inflammatory bowel disease: etiology and pathogenesis Gastroenterology 115 182 205 10.1016/S0016-5085(98)70381-6 1:STN:280: DyaK1czitlGjtg%3D%3D 9649475 (Pubitemid 28307304)
    • (1998) Gastroenterology , vol.115 , Issue.1 , pp. 182-205
    • Fiocchi, C.1
  • 5
    • 51049094931 scopus 로고    scopus 로고
    • Detection of enterohepatic and gastric Helicobacter species in fecal specimens of children with Crohn's Disease
    • 10.1111/j.1523-5378.2008.00607.x 1:CAS:528:DC%2BD1cXpslKns7w%3D 18665930
    • SM Man L Zhang AS Day S Leach HM Mitchell 2008 Detection of enterohepatic and gastric Helicobacter species in fecal specimens of children with Crohn's Disease Helicobacter 13 234 238 10.1111/j.1523-5378.2008.00607.x 1:CAS:528:DC%2BD1cXpslKns7w%3D 18665930
    • (2008) Helicobacter , vol.13 , pp. 234-238
    • Man, S.M.1    Zhang, L.2    Day, A.S.3    Leach, S.4    Mitchell, H.M.5
  • 6
    • 60849125086 scopus 로고    scopus 로고
    • Non-jejuni Campylobacter species are associated with Crohn's disease in children
    • 10.1128/JCM.01949-08
    • L Zhang SM Man AS Day, et al. 2009 Non-jejuni Campylobacter species are associated with Crohn's disease in children J Clin Micro 47 453 455 10.1128/JCM.01949-08
    • (2009) J Clin Micro , vol.47 , pp. 453-455
    • Zhang, L.1    Man, S.M.2    Day, A.S.3
  • 7
    • 39649100206 scopus 로고    scopus 로고
    • Active Crohn's disease and ulcerative colitis can be specifically diagnosed and monitored based on the biostructure of the fecal flora
    • DOI 10.1002/ibd.20330
    • A Swidsinski V Loening-Baucke M Vaneechoutte Y Doerffel 2008 Active Crohn's disease and ulcerative colitis can be specifically diagnosed and monitored based on the biostructure of the fecal flora Inflamm Bowel Dis 14 147 161 10.1002/ibd.20330 18050295 (Pubitemid 351288036)
    • (2008) Inflammatory Bowel Diseases , vol.14 , Issue.2 , pp. 147-161
    • Swidsinski, A.1    Loening-Baucke, V.2    Vaneechoutte, M.3    Doerffel, Y.4
  • 8
    • 0035082973 scopus 로고    scopus 로고
    • Different subsets of enteric bacteria induce and perpetuate experimental colitis in rats and mice
    • DOI 10.1128/IAI.69.4.2277-2285.2001
    • HC Rath M Schultz R Freitag, et al. 2001 Different subsets of enteric bacteria induce and perpetuate experimental colitis in rats and mice Infect Immun 69 2277 2285 10.1128/IAI.69.4.2277-2285.2001 1:CAS:528: DC%2BD3MXisVSlsrw%3D 11254584 (Pubitemid 32241818)
    • (2001) Infection and Immunity , vol.69 , Issue.4 , pp. 2277-2285
    • Rath, H.C.1    Schultz, M.2    Freitag, R.3    Dieleman, L.A.4    Li, F.5    Linde, H.-J.6    Scholmerich, J.7    Sartor, R.B.8
  • 9
    • 0034116557 scopus 로고    scopus 로고
    • Antibiotic therapy attenuates colitis in interleukin 10 gene-deficient mice
    • 10.1016/S0016-5085(00)70362-3 1:CAS:528:DC%2BD3cXktlaiurk%3D 10833484
    • KL Madsen JS Doyle MM Tavernini, et al. 2000 Antibiotic therapy attenuates colitis in interleukin 10 gene-deficient mice Gastroenterology 118 1094 1105 10.1016/S0016-5085(00)70362-3 1:CAS:528:DC%2BD3cXktlaiurk%3D 10833484
    • (2000) Gastroenterology , vol.118 , pp. 1094-1105
    • Madsen, K.L.1    Doyle, J.S.2    Tavernini, M.M.3
  • 10
    • 0032962075 scopus 로고    scopus 로고
    • Lactobacillus species prevents colitis in interleukin 10 gene-deficient mice
    • DOI 10.1016/S0016-5085(99)70013-2
    • KL Madsen JS Doyle LD Jewell MM Tavernini RN Fedorak 1999 Lactobacillus species prevents colitis in interleukin 10 gene-deficient mice Gastroenterology 116 1107 1114 10.1016/S0016-5085(99)70013-2 1:STN:280:DyaK1M3jvVyrtg%3D%3D 10220502 (Pubitemid 29203020)
    • (1999) Gastroenterology , vol.116 , Issue.5 , pp. 1107-1114
    • Madsen, K.L.1    Doyle, J.S.2    Jewell, L.D.3    Tavernini, M.M.4    Fedorak, R.N.5
  • 11
    • 0031915148 scopus 로고    scopus 로고
    • Early lesions of recurrent Crohn's disease caused by infusion of intestinal contents in excluded ileum
    • DOI 10.1016/S0016-5085(98)70476-7
    • GR D'Haens K Geboes M Peeters, et al. 1998 Early lesions of recurrent Crohn's disease caused by infusion of intestinal contents in excluded ileum Gastroenterology 114 262 267 10.1016/S0016-5085(98)70476-7 9453485 (Pubitemid 28093532)
    • (1998) Gastroenterology , vol.114 , Issue.2 , pp. 262-267
    • D'Haens, G.R.1    Geboes, K.2    Peeters, M.3    Baert, F.4    Penninckx, F.5    Rutgeerts, P.6
  • 12
    • 49849086533 scopus 로고    scopus 로고
    • Sustained modulation of intestinal microflora by exclusive enteral nutrition used to treat children with Crohn's disease
    • 10.1111/j.1365-2036.2008.03796.x 1:CAS:528:DC%2BD1cXhtF2hs7%2FL 19145728
    • ST Leach HM Mitchell WR Eng L Zhang AS Day 2008 Sustained modulation of intestinal microflora by exclusive enteral nutrition used to treat children with Crohn's disease Aliment Pharmacol Ther 28 724 733 10.1111/j.1365-2036.2008. 03796.x 1:CAS:528:DC%2BD1cXhtF2hs7%2FL 19145728
    • (2008) Aliment Pharmacol Ther , vol.28 , pp. 724-733
    • Leach, S.T.1    Mitchell, H.M.2    Eng, W.R.3    Zhang, L.4    Day, A.S.5
  • 13
    • 68049093112 scopus 로고    scopus 로고
    • Antibiotics and probiotics in inflammatory bowel disease: Why, when, and how
    • 10.1097/MOG.0b013e32832b20bf 1:CAS:528:DC%2BD1MXnsVegsrc%3D 19444096
    • C Prantera ML Scribano 2009 Antibiotics and probiotics in inflammatory bowel disease: why, when, and how Curr Opin Gastroenterol 25 329 333 10.1097/MOG.0b013e32832b20bf 1:CAS:528:DC%2BD1MXnsVegsrc%3D 19444096
    • (2009) Curr Opin Gastroenterol , vol.25 , pp. 329-333
    • Prantera, C.1    Scribano, M.L.2
  • 14
    • 23744444350 scopus 로고    scopus 로고
    • An open-label evaluation of rifaximin in the treatment of active Crohn's disease
    • DOI 10.1185/030079905X53252, 2931
    • I Shafran LK Johnson 2005 An open-label evaluation of rifaximin in the treatment of active Crohn's disease Curr Med Res Opin 1 1165 1169 10.1185/030079905X53252 (Pubitemid 41140719)
    • (2005) Current Medical Research and Opinion , vol.21 , Issue.8 , pp. 1165-1169
    • Shafran, I.1    Johnson, L.K.2
  • 15
    • 33646884826 scopus 로고    scopus 로고
    • Antibiotic treatment of Crohn's disease: Results of a multicentre, double blind, randomized, placebo-controlled trial with rifaximin
    • DOI 10.1111/j.1365-2036.2006.02879.x
    • C Prantera H Lochs M Campieri, et al. 2006 Antibiotic treatment of Crohn's disease: results of a multicentre, double blind, randomized, placebo-controlled trial with rifaximin Aliment Pharmacol Ther 23 1117 1125 10.1111/j.1365-2036.2006.02879.x 1:CAS:528:DC%2BD28Xlt1aktb8%3D 16611272 (Pubitemid 43779351)
    • (2006) Alimentary Pharmacology and Therapeutics , vol.23 , Issue.8 , pp. 1117-1125
    • Prantera, C.1    Lochs, H.2    Campieri, M.3    Scribano, M.L.4    Sturniolo, G.C.5    Castiglione, F.6    Cottone, M.7
  • 16
    • 70349751968 scopus 로고    scopus 로고
    • Use and safety of rifaximin in children with inflammatory bowel disease
    • 10.1097/MPG.0b013e3181a0d269 1:CAS:528:DC%2BD1MXhtFOhtr3M
    • P Muniyappa R Gulati F Mohr V Hupertz 2009 Use and safety of rifaximin in children with inflammatory bowel disease Pediatr Gastroenterol Nutr 49 400 404 10.1097/MPG.0b013e3181a0d269 1:CAS:528:DC%2BD1MXhtFOhtr3M
    • (2009) Pediatr Gastroenterol Nutr , vol.49 , pp. 400-404
    • Muniyappa, P.1    Gulati, R.2    Mohr, F.3    Hupertz, V.4
  • 17
    • 37849015933 scopus 로고    scopus 로고
    • "ecologic niche" therapy for Crohn's disease with adjunctive rifaximin antibiotic treatment followed by Flora-Q probiotic maintenance therapy
    • 18184139
    • DB Doman HJ Goldberg MI Golding 2008 "Ecologic niche" therapy for Crohn's disease with adjunctive rifaximin antibiotic treatment followed by Flora-Q probiotic maintenance therapy Am J Gastroenterol 103 251 252 18184139
    • (2008) Am J Gastroenterol , vol.103 , pp. 251-252
    • Doman, D.B.1    Goldberg, H.J.2    Golding, M.I.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.